2Tavassoli FA, Devilee P. World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. Lyon:IARC ,2003 : 169.
3De Backer A, Madem GC, Hakvoort-Cammel FG, et al. Study of the factors associated with recurrence in children with sacrococcygeal teratoma. J Pediatr Surg ,2006,41 (1): 173-181.
4Cavalla P, Dutto A, Piva R, et al. Cyclin D1 expression in gliomas. Acta Neuropathol, 1998,95 (2) : 131-135.
5Cavalla P, Piva R, Bortolotto S, et al. p27/kipl expression in oligodendrogliomas and its possible prognostic role. Aeta Neuropathol, 1999,98 (6) :629-634.
6Heifetz SA,Cushing B, Giller R, et al. Immature teratomas in children: pathologic considerations: a report from the combined pediatric oncology group/children's cancer group. Am J Surg Pathol, 1998,22 (9) :1115-1124.
7Hawkins E, Issacs H, Cushing B, et al. Occult malignancy in neonatal sacrococcygeal teratomas. A report from a Combined Pediatric Oncology Group and Children's Cancer Group study. Am J Pediatr Hematol Oncol, 1993,15 (4) :406-109.
8Li H, Hong W, Zhang R, et al. Retrospective analysis of 67 consecutive cases of pure ovarian immature teratoma. Chin Med J (Engl) ,2002,115 (10) : 1496-1500.
9Schmidt D, Kommoss F. Teratoma of the ovary: clinical and pathological differences between mature and immature teratomas. Pathologe, 2007,28 ( 3 ) :203-208.
10O'Connor DM, Norris HJ. The influence of grade on the outcome of stage Ⅰ ovarian immature (malignant) teratomas and the reproducibility of grading. Int J Gynecol Pathol, 1994, 13 (4) : 283 -289.
